Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3922]
News [11382]
Articles [47]
Editorials [10]
Conferences [197]
elearning [4]
The WIN symposium 2019
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
Accelerated tumour growth due to immunotherapy: Fact or fiction?
Dr Marina Garassino - National Tumor Institute, Milan, Italy
Accelerated tumour growth due to immunotherapy: Fact or fiction? ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
18 Apr 2019
Biomarkers of systemic inflammation linked to reduced clinical activity of...
Luciana Molinero - Genentech, San Francisco, USA
Biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monotherapy in metastatic TNBC ( Luciana Molinero - Genentech, San Francisco, USA )
18 Apr 2019
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
15 Apr 2019
5' UTR mutations in prostate cancer
Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA
5' UTR mutations in prostate cancer ( Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019
Cancer preventive vaccine used in mouse model of Lynch syndrome
Prof Steven Lipkin - Weill Cornell Medical College, New York, USA
Cancer preventive vaccine used in mouse model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )
15 Apr 2019
ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory...
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
15 Apr 2019
Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative...
Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA
Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer ( Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA )
15 Apr 2019
Talimogene laherparepvec combined with neoadjuvant chemotherapy for non...
Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA
Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer ( Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA )
15 Apr 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation